Editorial reviews · 11 October 2026 · AI-assisted · not independently peer reviewed
THE CURRENT READOUT
The lead. The challenge. The open question.
These summaries reflect our existing, dated reports. “Interesting” means worth checking next, not proven effective. Open each report for its primary sources, methods and limits.
R-004 / V1.1PROVISIONAL PRIORITY
Can better fat handling protect neurons?
Protective cell states · 8 selected primary publications
Why it is interesting
Selected mouse and cell studies point to lipid handling as a lead. The correction review retained the direction of partial protection in one genetic experiment.
What challenges it
The correction is not independent replication. Lipid-droplet handling can also be protective in other cell contexts; reducing droplets indiscriminately is not a supported strategy.
Still unresolved
No reviewed candidate establishes neuronal protection, tau safety and vascular safety together.
The comparison found different outcomes across interventions, cell states and disease models. Pathology and activation mode are useful variables to investigate.
What challenges it
A chronic agonist experiment worsened tau seeding and neuritic injury. The reviewed AL002 clinical trial did not establish clinical benefit.
Still unresolved
Differences in model, dose and design prevent a simple “early helps, late harms” rule or a validated human treatment window.
The targeted review follows links between TREM2, microglial metabolism and vascular outcomes into primary studies.
What challenges it
Supporting experiments sit alongside conflicting findings and a negative clinical trial. An abstract connection alone cannot establish a protective mechanism.
Still unresolved
Which leads hold up when neuronal injury, tau and vascular outcomes are assessed separately?
Literature synthesis, not MNEME laboratory experiments. These reports do not identify an established safe treatment or cure.
FROM UNCERTAINTY TO THE NEXT SEARCH
Give Scout a useful direction.
Proposed editorial queue. These links select Scout’s existing broad tracks; they do not launch a scan, change its search rules or complete the targeted review.
READCHALLENGESEARCH AGAIN
Illustrative research cycle · not live progress
01 / REPLICATION
Find the second test.
Look for independent tests of the lipid-handling intervention and neuronal outcome. Check corrected endpoints and overlapping authors or datasets.
Look for neuronal injury, tau spread and vascular outcomes in the same intervention context. Missing terms are not proof that an endpoint was unmeasured.
Scout retrieves and flags records. Independent replication, corrected data, causal interpretation and safety require source-level human review. Follow actual runs and saved receipts on Scout’s page ↗.
COMPLETED RESEARCH RUNS
Shared snapshots · file integrity checked on load
Loading published reports…
Earlier runs and partial snapshots
PUBLICATION WATCH
A visible record. Every research round.
Server-side scans preserve shared evidence snapshots even when this website is closed. Each completed round compares source records with the previous snapshot. Newly indexed records can include older publications; a missing record does not itself mean a retraction.
Checking the research log…
Automated metadata reports do not update the editorial research brief or establish treatment effectiveness. Retrieval caps can affect comparisons. The log shows the latest 60 completed topic runs.
CONNECTION EXPLORER · ABSTRACT ANALYSIS
Follow the connections. Question the gaps.
We analyze available publication abstracts using an explicit biological vocabulary. A line means two concepts occur in the same sentence. Select a connection to inspect its source papers. These are reading leads, not validated mechanisms or new discoveries.
Loading abstract analysis…
Questions suggested by indirect connections
These prompts join two observed links through a shared concept where no direct same-sentence link was found in this sample. This is not evidence that the relationship is absent from science, novel, or causal.
Co-mentions can describe background knowledge, uncertainty or negative results. A caution-word flag does not determine whether studies contradict one another. Independent cohort overlap, study quality and contradictory findings have not been assessed. Human review is required before making biological claims.
AI-assisted editorial synthesis of three selected primary studies. Not peer reviewed. Purposive selection, not a systematic review; independent expert assessment is pending.
01 · Human tissue
Astrocyte programs
A 2024 study examined roughly 1.3 million cells across six brain regions from 48 people. It linked an astrocyte gene program involving choline and polyamine metabolism to preserved cognition.
Interpretation: a candidate pathway for follow-up, not evidence that changing it will improve memory. Multiple tissue samples from one person are not independent participants.
A 2025 study analyzed cerebrospinal-fluid proteins in 3,397 individuals from six cohorts. Its YWHAG:NPTX2 ratio provided information about cognitive impairment beyond amyloid and tau markers.
Interpretation: a prognostic association can help study resilience, but does not establish a treatment target. External validation and suitability for each intended clinical use remain separate questions.
A 2026 human-brain study associated different microglial programs with resilience in octogenarians and cognitively intact centenarians. The resilience patterns differed between these groups.
Interpretation: resilience should not be treated as a single uniform biological state. These observations do not demonstrate that modifying microglia prevents dementia.
Does a prespecified astrocyte pathway score remain associated with cognition after accounting for pathology, donor characteristics, and cell composition in an independent cohort?
Proposed, not executed: establish dataset access and donor overlap; freeze the score and model before validation; use donor-level uncertainty and multiple-testing controls. A null or reversed association would count against the hypothesis. We have not reanalyzed these studies’ participant-level data, assessed all study biases, or pooled their effect sizes.
REPEAT THE WORK
Run a fresh literature scan.
This makes real requests to Europe PMC and analyzes the returned metadata in your browser. The result is downloadable and stays in this session. It does not update the shared reports or run after you close the page.
METHODS & REPRODUCIBILITY
Trust the trail. Not a counter.
What is counted?
Matching publication records, not patients or verified discoveries. We deduplicate DOI or source IDs, exclude records labelled as preprints, retractions, withdrawals or errata, and count publication types and title-term matches.
What can it miss?
One database and a narrow query cannot cover all evidence. Indexing can lag or be wrong. We do not automatically assess risk of bias, distinguish all human and animal work, verify effect sizes, or establish causality. Reviews and primary studies remain mixed and labelled.
What does a hash prove?
The downloadable snapshot matches its displayed checksum and its counts can be recomputed. This detects inconsistency, not scientific truth, authorship, or an independently certified timestamp. No external timestamp anchor is claimed.
